Nov 20, 2025 9:54pm EST Inhibikase Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock and Pre-Funded Warrants
Nov 20, 2025 4:12pm EST Inhibikase Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants